| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 27.142 | 48.916 | 52.199 | 69.433 | 91.360 |
| Total Income - EUR | - | - | - | - | - | 27.142 | 48.979 | 52.203 | 69.870 | 114.861 |
| Total Expenses - EUR | - | - | - | - | - | 7.490 | 16.107 | 31.470 | 26.127 | 65.347 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 19.653 | 32.873 | 20.733 | 43.743 | 49.513 |
| Net Profit/Loss - EUR | - | - | - | - | - | 19.392 | 32.424 | 20.289 | 43.079 | 46.937 |
| Employees | - | - | - | - | - | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Cat Cataliste Analysis Telemed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 27.916 | 20.573 | 14.631 | 53.392 |
| Current Assets | - | - | - | - | - | 21.498 | 24.217 | 38.683 | 40.226 | 54.080 |
| Inventories | - | - | - | - | - | 0 | 394 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 5.847 | 6.873 | 9.188 | 16.245 | 4.263 |
| Cash | - | - | - | - | - | 15.651 | 16.951 | 29.494 | 23.981 | 49.817 |
| Shareholders Funds | - | - | - | - | - | 19.433 | 32.464 | 44.209 | 45.403 | 47.321 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 2.065 | 19.670 | 15.046 | 9.454 | 60.150 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7112 - 7112" | |||||||||
| CAEN Financial Year |
7112
|
|||||||||
Comments - Cat Cataliste Analysis Telemed S.r.l.